Compare Stocks: PLAB vs. AXTI vs. AMKR vs. ACMR

Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
PLABAXTIAMKRACMR
-21.90%+75.54%-0.16%+38.61%

Market Snapshot

Current market context for the selected companies.

Performance

Absolute returns and relative performance versus SPY.

Metric PLABAXTIAMKRACMR
1 Month+3.6%+52.4%+6.0%+9.8%
1 Month vs SPY+0.3%+49.1%+2.7%+6.5%
3 Months-43.6%-46.9%-32.9%-10.8%
3 Months vs SPY-45.6%-48.9%-34.9%-12.8%
6 Months-30.7%+59.0%-4.9%+15.5%
6 Months vs SPY-41.1%+48.6%-15.3%+5.0%
1 Year+36.8%+2194.4%+100.6%+174.5%
1 Year vs SPY+17.7%+2175.2%+81.4%+155.4%
2 Years+23.2%+2194.4%+45.9%+296.5%
2 Years vs SPY-13.3%+2157.8%+9.4%+260.0%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric PLABAXTIAMKRACMR
Revenue Growth-0.5%164.8%25.6%36.0%
Earnings Growth270.5%218.2%180.6%
Gross Margin33.8%32.2%15.5%43.8%
Operating Margin20.1%21.9%10.5%17.0%
Net Margin18.5%3.2%7.4%14.5%
Return on Equity13.2%1.0%12.5%11.6%
Return on Assets6.8%0.3%4.6%3.2%

Valuation

Common valuation multiples shown side by side.

Metric PLABAXTIAMKRACMR
P / E10.82,248.321.837.6
Forward P / E14.929.317.227.3
P / S2.035.21.65.4
P / B1.44.92.63.0
EV / Sales1.832.51.64.7
EV / EBIT8.9148.515.727.5
P / FCF44.3-99.6-31.9-29.8
FCF Yield2.3%-1.0%-3.1%-3.4%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric PLABAXTIAMKRACMR
Free Cash Flow$39.00M-$44.42M-$378.79M-$186.61M
Operating Cash Flow$282.16M-$5.76M$1.19B-$6.60M
Debt / Equity0.2%10.7%57.1%14.5%

Earnings Outlook

Upcoming earnings expectations when available.

Metric PLABAXTIAMKRACMR
Next Earnings2026-10-292026-10-262026-11-04
EPS Estimate0.310.780.48
Revenue Estimate66M2.04B308.55M
EPS Growth+1126.7%+52.4%+33.3%
Revenue Growth+136.1%+2.9%+14.6%
Analyst Coverage583